Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Bullboard (NYSE:PFE)

View:
Post by AlphaTrader1024on Nov 22, 2024 2:02pm

Pfizer (PFE): Defensive Positioning with Yield Stability

PFE remains a defensive play amid sector rotation, with pipeline news being critical to reversing current trends. Its dividend stability appeals to yield-focused investors, offering reliability in ...more  
Post by AlphaChart200on Nov 22, 2024 12:14pm

Pfizer and MYNZ: Defensive Stability with Growth Potential

PFE’s pipeline stability supports its defensive appeal, while MYNZ’s innovative focus on diagnostics offers an attractive high-growth alternative within healthcare.
Post by CapitalPulse77on Nov 22, 2024 11:44am

activists in play – $PFE shake-up?

Starboard’s involvement could force Pfizer to trim the fat and get focused. Bullish on potential restructuring. Also monitoring $MYNZ, hearing whispers about big moves.
Post by Jonathon Brownon Nov 21, 2024 6:55am

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

Post by ecolo101on Nov 18, 2024 10:01pm

Way oversold

Just over reaction at the moment. It generates money and there is too many projects on the table. glta dyodd
Comment by ozkan123on Nov 15, 2024 1:28pm

RE:Maybe $25

Just a question,  If you buy PFE on the Canadian NEO exchange, are you still eligible to receive dividends? and in US $$.  If so, then I'll assume that as long as it's in a RRSP then ...more  
Post by ecolo101on Nov 15, 2024 12:09pm

Well! It happens

Kennedy Junior got the head of the health department....ouch Just Watch him over the next year, hopefully somebody can find a best approach to discuss worm brain Disease ha ha ha. For those who heard ...more  
Post by ecolo101on Nov 07, 2024 5:20pm

Ex dividend date

Tomorrow, so today was the day to get in. Dividend 6.12% annually so $1.68 or $0.42 per quarter. big pharma seems to be waiting to see if Kennedy will come on top nominated by Trump...this could be ...more  
Post by ecolo101on Nov 04, 2024 8:53pm

Maybe $25

Wait wait wait forget the dividend if it goes to a lower entrance point. dyodd
Post by ecolo101on Nov 01, 2024 1:48pm

Ex dividend date coming soon

November 8th and if you are registered you will be eligible to $0.42 , not bad at all in a declining interest rate environment... glta dyodd
Post by whytestockson Sep 26, 2024 7:30pm

3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold at Le

Just In: $PFE 3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade2024-09-26 04:07:00 ET It will be over a decade before I start relying on dividend income from my stock portfolio. ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities